IDEAYA Biosciences, Inc.
IDYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001676725
In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in IDEAYA Biosciences, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 199
- −3 vs. Q1 2024
- Shares held
- 82.5M
- +3.52M (+4.5%) vs. Q1 2024
- Total value
- $2.90B
- −$568.0M (−16.4%) vs. Q1 2024
- New holders
- 29
- 91 more added
- Sold out
- 32
- 61 more reduced
2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IDYA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 285 | $3.80B |
| Q1 2026 | 254 | $3.16B |
| Q4 2025 | 246 | $3.32B |
| Q3 2025 | 224 | $2.56B |
| Q2 2025 | 204 | $2.04B |
| Q1 2025 | 207 | $1.54B |
| Q4 2024 | 206 | $2.36B |
| Q3 2024 | 209 | $2.91B |
| Q2 2024 | 199 | $2.90B |
| Q1 2024 | 204 | $3.47B |
| Q4 2023 | 157 | $2.35B |
| Q3 2023 | 144 | $1.61B |
| Q2 2023 | 138 | $1.33B |
| Q1 2023 | 128 | $625.4M |
| Q4 2022 | 117 | $835.0M |
| Q3 2022 | 112 | $667.1M |
| Q2 2022 | 96 | $489.0M |
| Q1 2022 | 103 | $392.9M |
| Q4 2021 | 110 | $820.7M |
| Q3 2021 | 91 | $837.9M |
| Q2 2021 | 84 | $533.4M |
| Q1 2021 | 89 | $558.6M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding IDEAYA Biosciences, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Superstring Capital Management LP | 0 | $0 | 0.00% | −217,070−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −123,900−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −83,484−100.0% | Sold out |
| Harvest Investment Services, LLC | 0 | $0 | 0.00% | −66,744−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −66,332−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −59,180−100.0% | Sold out |
| Readystate Asset Management LP | 0 | $0 | 0.00% | −42,943−100.0% | Sold out |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −33,007−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −32,430−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −23,354−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −15,722−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −15,473−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −15,237−100.0% | Sold out |
| Boston Partners | 0 | $0 | 0.00% | −13,391−100.0% | Sold out |
| Redmond Asset Management, LLC | 0 | $0 | 0.00% | −12,754−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −11,200−100.0% | Sold out |
| CIBC World Markets Inc. | 0 | $0 | 0.00% | −8,867−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −7,029−100.0% | Sold out |
| Danske Bank A/S | 0 | $0 | 0.00% | −6,945−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −5,850−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −4,942−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −4,888−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −4,877−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −3,460−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −2,994−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,497−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −442−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| First Command Advisory Services, Inc. | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |
| Ziegler Capital Management, LLC | – | – | – | – | Not filed |